Medical Treatment in China: What You Can Book, What a Cure Shop Isn't
This is the English hub for hospital matching in China — oncology, diabetes, labelled cell and gene products, visas — not a wellness catalogue and not a cure shop. Sequence: records, named centre, invitation. We do not sell a universal cure. Send the file. About 24 hours. No obligation to book.
Quick answer
This is the English hub for hospital matching in China — oncology, diabetes, labelled cell and gene products, visas — not a wellness catalogue and not a cure shop. China is a high-volume public system plus a noisy facilitator layer. The useful sequence is always the same: diagnosis and records, then a named centre, then invitation/visa. We do not sell a universal cure. Send the file. About 24 hours. No obligation to book.
What the papers and official notices say
Oncology follows NCCN/CSCO maps and NMPA labels (CD19/BCMA CAR-T; satri-cel only for a narrow gastric/GEJ group; SPHIC particle fee RMB 278,000). Diabetes follows WHO/ADA: insulin for type 1, proven drugs for type 2; Cell 2024 n=1 is research. Entry rules follow embassy circulars (KZ waiver 30 days / 90 in 180 including medical, as of April 2026). Gene therapy that is actually labelled includes BBM-H901 for adult haemophilia B (10 April 2025), not a pan-cancer shot.
What actually changes the plan
Records first, then a hospital shortlist
Pathology, imaging, labs and prior therapy decide the department — oncology, diabetes, CAR-T or proton — not a generic China package.
Named centres, not brand slogans
We match Beijing, Shanghai, Guangzhou and other high-volume hospitals to the diagnosis, including when a famous name is the wrong fit.
Visa, interpreter, stay
Invitation letters, visa-free or transit rules by passport, appointments, and communication with the medical team during the trip.
What this page helps you decide
Headline vs hospital pathway
We say when a story is a trial, when it is approved care, and when it is only a marketed package.
Cost drivers in writing
What a range usually includes (review, stay, interpreter) and what hospitals bill separately (drugs, cells, ICU).
English case workflow
Remote pre-check, one next step at a time, no pressure to book before the file is reviewed.
Evidence table
WHO/ADA, NCCN/NMPA, IARC, embassy KZ circular — the four maps this hub uses.
| Source | What it says | Relevance to patients |
|---|---|---|
| WHO / ADA (current / 2026) | Type 1 needs insulin; no walk-in cell cure | Diabetes door is standard care unless a trial ID exists. |
| NCCN + NMPA (current) | Stage maps; labelled CAR-T products are narrow | Cancer door is histology first. |
| IARC GLOBOCAN China (2024) | Lung first in cases and deaths | Volume, not a ranking. |
| Embassy KZ notice (Apr 2026) | 30 days / 90 in 180 including medical | Visa door is a calendar, not a package. |
| NMPA BBM-H901 (Apr 2025) | Adult haemophilia B gene therapy | Gene door is a product name, not “gene for cancer.” |
Who this page is for
Oncology patients and families
Need a department that treats this tumour type and stage — including CAR-T or proton when the file supports it.
Diabetes and chronic-care patients
Came from China-cure headlines and need a realistic split between standard endocrinology and experimental programmes.
Caregivers arranging the trip
Want documents, visa path, budget ranges and one coordinator — not a slogan and a payment link.
What you can actually book
A file label: standard care at a named public centre, a labelled product at a designated room, a registered trial, or a no. Then invitation paperwork if a hospital accepts.
What moves the cost
Case review
No charge to start
File review • Direction (cancer / diabetes / other) • First clinic shortlist • What to send next
Coordinated trip
Quoted after records
Hospital matching • Written cost drivers • Visa support • Interpreter • On-site coordination
These are routing steps, not a hospital package SKU. Published procedure examples stay in the evidence/cost sections only when a source exists. Hospital, drugs, stay, interpreter and travel are quoted separately after records.
What happens next
Send the file
Diagnosis, staging or labs, prior treatment, medication list, and what you want from the trip.
Compare real options
Clinics, methods, evidence level (standard / trial / advertised), timelines and budget ranges.
Travel only if accepted
Invitation, visa path, interpreter and stay — after a hospital is willing to see the case.
Request a preliminary case review
Tell us the basics of your case. When you submit, WhatsApp will open with the information you entered so you can review it before sending. This is a preliminary routing request, not a diagnosis, treatment acceptance, trial enrollment, visa decision, or medical advice.
Frequently asked questions
What can you actually book in China?
Standard care at a named public centre, a labelled product at a designated room, a registered trial, or a no. Then invitation paperwork if a hospital accepts.
Do you sell a cure in China package?
No. See the cure-in-China router if you landed on that phrase.
How much does treatment in China cost?
It depends on the desk. Diabetes MSC ads often USD 12,000-25,000. SPHIC particle course RMB 278,000 published. CAR-T is a different invoice. We itemise after records.
Is Parkmega a hospital?
No. Matching service.
What if I only want a check-up?
Say so on the form so we do not mix you into oncology.
What records should I send?
Diagnosis, recent labs or staging, the claim or PDF you saw, passport nationality if visa is the question.
Can I start without records?
No. Pay-before-file is a red flag.
How fast do you reply?
About 24 hours. No obligation to book.
Do I pay before you read the file?
No. Payment required before a file review is a red flag. Average reply about 24 hours. No obligation to book.
Red flags in offers
One SKU for check-up, stem cells, CAR-T and “cure in China.” That mix is how money is wired to the wrong desk. We route: cancer, diabetes, stem-cell diabetes, CAR-T, gene therapy, proton, visa, what “cure” means.
No diagnosis, but a price.
One clinic for diabetes, autism, cancer and COPD.
Visa or cure promised before a hospital names dates.
Pay before records are read.
Sources
WHO diabetes fact sheet; ADA Standards 2026.
NCCN maps; NMPA CAR-T and BBM-H901 labels; IARC GLOBOCAN 2024 China.
Chinese Embassy in Kazakhstan, 24 April 2026.
SPHIC published particle-course fee.
This page is a matching hub, not a hospital and not a cure product.
Freshness label on this page: 2026-08-15